Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 09:00 ET | Source: Nouscom Srl

Nouscom to Present New Positive Phase 1b/2 Clinical and Translational Data on NOUS-209 Immunogenicity and Cancer Interception Potential in Lynch Syndrome Carriers at SITC 2025

Lynch Syndrome (LS) is a common hereditary condition that greatly increases lifetime risk of colorectal, endometrial, urothelial and other cancersNOUS-209 is an off-the-shelf immunotherapy...
October 30, 2025 07:41 ET | Source: Research and Markets

United States Cancer Immunotherapy Forecast Report 2025: A $71.65 Billion Market by 2033, Driven by Digital Transformation, AI Adoption, Cloud Demand, and Growth of Mobile and Web Applications

Dublin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The "United States Cancer Immunotherapy Market Report by Products, Application, End User, States and Company Analysis, 2025-2033" report has been added to ...
October 29, 2025 13:22 ET | Source: Research and Markets

Cancer Immunotherapy Market Size and Share Analysis: Growth Trends and Forecast Report 2025-2033

Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's...
October 28, 2025 09:30 ET | Source: SNS Insider pvt ltd

mRNA Technology Market Set to Reach USD 76.45 Billion, Growth Accelerated by Covid-19 Vaccine Success and Increasing Potential in Cancer Treatment – SNS Insider

Austin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- mRNA Technology Market Size & Growth Analysis: According to SNS Insider, the global mRNA technology market is estimated to have reached a valuation of...
August 08, 2025 08:30 ET | Source: SNS Insider pvt ltd

Bispecific Antibodies Market Size to Reach USD 220.82 Billion by 2032 | Oncology Drug Innovation and U.S. Market Leadership – SNS Insider

Austin, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Bispecific Antibodies Market Size & Trends: According to SNS Insider, the global Bispecific Antibodies Market was valued at USD 8.28 billion in 2023...
July 10, 2025 10:47 ET | Source: Research and Markets

PD-1 and PD-L1 Inhibitors Market Report 2025-2034 | Expanding Treatment Options to Impact Market Value, Rising Adoption of Immunotherapies and Regulatory Approvals to Drive Growth

Dublin, July 10, 2025 (GLOBE NEWSWIRE) -- The "PD-1 and PD-L1 Inhibitors Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The global PD-1 and PD-L1...
June 24, 2025 08:33 ET | Source: Research and Markets

Interleukin-2 Market Analysis and Forecast, 2025-2035 | Engineered IL-2 Therapies Lead Innovations in Immunotherapy

Dublin, June 24, 2025 (GLOBE NEWSWIRE) -- The "Interleukin-2 Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's...
June 17, 2025 03:30 ET | Source: AKAMPION

Captain T Cell Joins Bayer Co.Lab Berlin to Accelerate Autologous and Allogeneic TCR-T Cell Therapy Programs for Cancer Patients

Berlin, Germany – June 17th, 2025 – Captain T Cell GmbH, a biotech company developing next-generation TCR-based cell therapies for patients with solid tumors, today announced that it has been selected...
April 30, 2025 04:56 ET | Source: Research and Markets

Analysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global cancer immunotherapy...
April 29, 2025 15:30 ET | Source: Nouscom Srl

Nouscom Presents Positive Final Results from Completed Phase Ib/II Study of Neoantigen Immunotherapy NOUS-209 at AACR 2025, Demonstrating a Highly Potent and Durable Immune Response in Lynch Syndrome Carriers

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of cancer, especially colorectal and endometrial, to as high as 80%NOUS-209 is an off-the-shelf...